Palombella Vito J. 4
4 · Surface Oncology, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+82,000→ 82,000 totalExercise: $9.02Exp: 2031-03-01→ Common Stock (82,000 underlying)
Footnotes (1)
- [F1]This option shall become exercisable in equal monthly installments over four years following February 9, 2021, so long as the reporting person remains an employee or other service provider of the Company on such dates.